CIHealthcare · Healthcare PlansThe 24 Wall Street analysts covering The Cigna Group hold a median 12-month price target of $345 — +19.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 75 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores The Cigna Group on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (98): The share price has been relatively steady.
Accruals (38): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +19.1% from it.
Of the 20 most recent actions, 5 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Oct 2026 | Piper Sandler | Maintains | Overweight | $346 → $370 |
| 1 Oct 2026 | RBC Capital | Reiterates | Outperform | $337 |
| 4 Aug 2026 | Jefferies | Downgrade | Hold | — |
| 4 Aug 2026 | Jefferies | Downgrade | Hold | $336 → $307 |
| 3 Aug 2026 | Raymond James | Downgrade | Outperform | — |
| 3 Aug 2026 | Raymond James | Downgrade | Outperform | $350 → $320 |
| 31 July 2026 | Barclays | Maintains | Equal-Weight | $304 → $310 |
| 31 July 2026 | Barclays | Maintains | Equal-Weight | — |
| 31 July 2026 | Guggenheim | Maintains | Buy | — |
| 31 July 2026 | Guggenheim | Maintains | Buy | $338 → $361 |
| 31 July 2026 | Wells Fargo | Maintains | Equal-Weight | $305 → $307 |
| 31 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 9 July 2026 | Bernstein | Maintains | Outperform | — |
| 9 July 2026 | Bernstein | Maintains | Outperform | $371 → $381 |
| 8 June 2026 | Mizuho | Maintains | Outperform | — |
| 26 May 2026 | Barclays | Downgrade | Equal-Weight | — |
| 22 May 2026 | UBS | Maintains | Buy | — |
| 20 May 2026 | Deutsche Bank | Downgrade | Hold | — |
| 20 May 2026 | Morgan Stanley | Maintains | Overweight | — |
| 5 May 2026 | Bernstein | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CI appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, The Cigna Group returned −2.0% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 53% of US stocks
Cheaper than 89% of US stocks
Cheaper than 48% of US stocks
Cheaper than 45% of US stocks
Higher than 43% of US stocks
Higher than 46% of US stocks
Higher than 9% of US stocks
Higher than 52% of US stocks
Higher than 53% of US stocks
Higher than 77% of US stocks
Higher than 73% of US stocks
Higher than 80% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
The Cigna Group has a market value of $74.7B and an enterprise value of $99.8B.
Revenue in the twelve months to 30 June 2026: $281.3B. The latest quarter grew 6.7% year on year.
Net income over the same four quarters: $7.0B, a 2.5% net margin.
Diluted earnings per share, trailing twelve months: $24.17.
Free cash flow in the twelve months to 30 June 2026: $9.1B.
The Cigna Group spent $1.3B on share buybacks and $1.6B on dividends in the twelve months to 30 June 2026.
Trailing P/E: 11.7×; forward P/E: 8.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.21%, paying out 25% of earnings.
The Cigna Group employs 65,669 people — $4.3M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own The Cigna Group — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research explains how its Style Scores help investors identify stocks rated highly for a particular investing style, and introduces Cigna as a strong value stock.
Why it matters — The item presents Cigna through Zacks’ value-investing framework, which may be relevant to CI watchers following style-based stock ratings.
The Cigna Group said it will release its third-quarter 2026 financial results on Thursday, November 5, 2026, and host a conference call that day.
Why it matters — CI watchers can note the date when the company plans to report quarterly results and discuss them on a call.
The article introduces Zacks Style Scores as a way for investors to identify highly rated stocks based on their investing style, and explains why readers should consider using them for Cigna (CI).
Why it matters — CI watchers may find the article’s discussion of Zacks’ stock-rating approach relevant when reviewing the company through different investing styles.
Cigna Healthcare introduced Health Sense, which connects information about individuals’ health, care and coverage to provide continuous personalized support and help them make informed decisions. The initiative is projected to reduce inefficient health care spending by 10% by 2030.
Why it matters — CI watchers may note the initiative’s stated focus on affordability and outcomes for employers and customers.
Seeking Alpha rates Cigna a 'Strong Buy,' citing compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. The article highlights strong Q2 2026 results, raised full-year EPS guidance, and a 10-14% annual EPS growth target through 2030 driven by AI and specialty pharmacy.
Why it matters — This matters to Cigna watchers because the report outlines the company's growth drivers—AI, specialty pharmacy, and share buybacks—and its targets for double-digit earnings growth through 2030.
The 24 Wall Street analysts covering The Cigna Group have a median 12-month price target of $345, with estimates ranging from $288 to $400. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 24 analysts covering The Cigna Group, 18 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Cigna Group 75 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, The Cigna Group ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).
No one can know that. What the data says: the median 12-month target from 24 analysts implies +19.1% from the last close, and Ticker Nerd's factor model ranks The Cigna Group 75 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering The Cigna Group publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $288 to $400 over the next 12 months.
The Cigna Group returned -2.0% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations.
The most recent item we track (Zacks Investment Research, 14 Oct 2026): "Here's Why Cigna (CI) is a Strong Value Stock". Zacks Investment Research explains how its Style Scores help investors identify stocks rated highly for a particular investing style, and introduces Cigna as a strong value stock.
The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.
CEO Mr. Brian Case Evanko C.F.A. · 65,669 employees · United States · https://www.thecignagroup.com
